Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioreactor Controls-III01:22

Bioreactor Controls-III

67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Upstream Processing01:27

Upstream Processing

97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Production of Antibiotics01:27

Production of Antibiotics

265
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
265
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94
Production of Biopesticides01:18

Production of Biopesticides

108
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
108
iChip01:24

iChip

105
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
105

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A framework for building a synthetic cell from the SynCell Asia Initiative.

Nature biotechnology·2026
Same author

Systems Metabolic Engineering of <i>Escherichia coli</i> for Efficient <i>de novo</i> Biosynthesis of 2,5-Dimethylpyrazine from Glucose.

Journal of agricultural and food chemistry·2026
Same author

Corrigendum to 'Expanding biotechnological applications of Yarrowia lipolytica: Key advances in the past decade' [Biotechnol. Adv. 88 (2026) 108835].

Biotechnology advances·2026
Same author

Expanding biotechnological applications of Yarrowia lipolytica: Key advances in the past decade.

Biotechnology advances·2026
Same author

Metabolic Engineering of Yeasts: A Key Cell Factory Platform for Advanced Biomanufacturing.

Journal of fungi (Basel, Switzerland)·2025
Same author

A Highly Efficient 5S rRNA-CRISPR/Cas9 Genome Editing Toolkit in <i>Acremonium chrysogenum</i>.

Journal of agricultural and food chemistry·2025

Related Experiment Video

Updated: May 2, 2026

Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability
09:27

Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability

Published on: April 22, 2016

17.3K

Advancements in Microbial Cell Engineering for Benzylisoquinoline Alkaloid Production.

Liyan Cao1, Desmond Teo2, Yuyang Wang1

  • 1State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianjin University of Science and Technology, No.29 the 13th Street TEDA, Tianjin 300457, PR China.

ACS Synthetic Biology
|November 23, 2024
PubMed
Summary

Microbial production of benzylisoquinoline alkaloids (BIAs) offers a sustainable alternative to plant extraction and chemical synthesis. This review highlights advances in engineering Escherichia coli and Saccharomyces cerevisiae for enhanced BIA yields.

Keywords:
Benzylisoquinoline alkaloids (BIAs)Microbial cell factoriesNatural productsSynthetic biologySystems metabolic engineering

More Related Videos

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

9.7K
A High-Yield Streptomyces Transcription-Translation Toolkit for Synthetic Biology and Natural Product Applications
07:59

A High-Yield Streptomyces Transcription-Translation Toolkit for Synthetic Biology and Natural Product Applications

Published on: September 10, 2021

4.0K

Related Experiment Videos

Last Updated: May 2, 2026

Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability
09:27

Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability

Published on: April 22, 2016

17.3K
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

9.7K
A High-Yield Streptomyces Transcription-Translation Toolkit for Synthetic Biology and Natural Product Applications
07:59

A High-Yield Streptomyces Transcription-Translation Toolkit for Synthetic Biology and Natural Product Applications

Published on: September 10, 2021

4.0K

Area of Science:

  • Biotechnology
  • Metabolic Engineering
  • Natural Product Synthesis

Background:

  • Benzylisoquinoline alkaloids (BIAs) are plant-derived compounds with significant pharmacological value.
  • Current production methods via plant extraction or chemical synthesis face limitations in yield and cost.
  • Microbial systems present a promising alternative for sustainable BIA production.

Purpose of the Study:

  • To review recent advancements in microbial production of BIAs.
  • To explore strategies for enhancing BIA yields in Escherichia coli and Saccharomyces cerevisiae.
  • To identify challenges and future research directions in microbial BIA synthesis.

Main Methods:

  • Metabolic engineering of microbial hosts (Escherichia coli and Saccharomyces cerevisiae).
  • Genomic approaches for pathway optimization.
  • Bioreactor-based production of various BIAs, including (S)-reticuline, morphinane, protoberberine, and aporphine alkaloids.

Main Results:

  • Demonstrated feasibility of using engineered microbes for BIA production.
  • Identified key strategies for improving BIA yields in microbial systems.
  • Highlighted progress in synthesizing diverse BIA classes.

Conclusions:

  • Microbial production is a viable and scalable strategy for obtaining valuable BIAs.
  • Continued research in metabolic engineering and synthetic biology will further optimize yields.
  • Addressing current challenges will unlock the full potential of microbial BIA synthesis.